The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125549081 12554908 1 I 20150318 20160713 20160713 PER US-ASTRAZENECA-2015SE27340 ASTRAZENECA 0.00 M Y 96.20000 KG 20160714 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125549081 12554908 1 PS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 ONE PUFF, TWO TIMES A DAY 21929
125549081 12554908 2 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 ONE PUFF, TWO TIMES A DAY 21929
125549081 12554908 3 SS LISINOPRIL. LISINOPRIL 1 Oral 0 20 MG TABLET QD
125549081 12554908 4 C TAMSULOSIN-HCL 2 Oral 0 .4 MG QD
125549081 12554908 5 C ALPRAZOLAM. ALPRAZOLAM 1 Oral 0 .5 MG BID
125549081 12554908 6 C ALPRAZOLAM. ALPRAZOLAM 1 Oral 0 .5 MG BID
125549081 12554908 7 C FINASTERIDE. FINASTERIDE 1 Oral 0 5 MG QD
125549081 12554908 8 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 0 20 MG QD
125549081 12554908 9 C HYDROCODONE HYDROCODONE 1 Oral 2 PILLS AND FOR EXTREME PAIN 3 PILLS 0 3.5 MG
125549081 12554908 10 C HYDROCODONE HYDROCODONE 1 Oral 2 PILLS AND FOR EXTREME PAIN 3 PILLS 0 325 MG
125549081 12554908 11 C GABAPENTIN. GABAPENTIN 1 Oral 0 300 MG TID
125549081 12554908 12 C SIMVASTATIN. SIMVASTATIN 1 Oral 0 20 MG QD
125549081 12554908 13 C AMLODIPINE BESYLATE. AMLODIPINE BESYLATE 1 Oral 0 10 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125549081 12554908 1 Chronic obstructive pulmonary disease
125549081 12554908 2 Emphysema
125549081 12554908 3 Blood pressure abnormal
125549081 12554908 4 Prostatic disorder
125549081 12554908 5 Anxiety
125549081 12554908 6 Chronic obstructive pulmonary disease
125549081 12554908 8 Gastrooesophageal reflux disease
125549081 12554908 9 Pain
125549081 12554908 10 Pain
125549081 12554908 11 Pain
125549081 12554908 12 Blood cholesterol abnormal
125549081 12554908 13 Blood pressure abnormal

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125549081 12554908 Intentional product misuse
125549081 12554908 Off label use
125549081 12554908 Oral mucosal discolouration
125549081 12554908 Oral pain
125549081 12554908 Paraesthesia oral

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125549081 12554908 1 201410 0
125549081 12554908 2 201410 0
125549081 12554908 3 2003 0
125549081 12554908 5 1999 0
125549081 12554908 6 1999 0
125549081 12554908 7 201408 0
125549081 12554908 8 2005 0
125549081 12554908 11 2010 0
125549081 12554908 12 2007 0
125549081 12554908 13 2003 0